Myriad Genetics $MYGN has been retreating sharply in the past couple of weeks. This is walking back price to where it began in 2018 after a bullish run in 2017. On the daily chart below we can see that price has fallen below the moving averages and the RSI has fallen below 30, all signs MYGN is turning bearish.MYGN Daily Chart(click to enlarge)Last Line of Defense:- The recent sell-off is pretty convincing of a market turning bearish.- However, there is still a last line of defense around the $30 area. - Even around $32, price will be on top of a rising trendline support. - Then just below $30, in the $27.50-$30 area, we have a couple of previous support pivots and the key central pivot area of a large consolidation range since 2007. (refer to the weekly chart below)Breakout:- As we can see on the weekly chart below, price has broken above a key resistance around $45 in 2018. This was the resistance of a long-term range between $14.15 and $45. - It is because this is such a critical breakout that I would consider respecting the support around $30 against such a sharp "falling knife".- A break below $27.40 however would likely kill the bullish breakout outlook.- The bullish outlook has upside towards the all-time-high around $60 as seen on the monthly chart below the weekly chart.MYGN Weekly Chart(click to enlarge)MYGN Monthly Chart(click to enlarge)